Astrazeneca PLC Sponsored ADR is a company in the U.S. stock market and it is a holding in 55 U.S.-traded ETFs. AZN has around 12.1M shares in the U.S. ETF market. The largest ETF holder of AZN is the Invesco QQQ Trust (QQQ), with approximately 8.11M shares. Investors may also find of interest that the ETF with the largest allocation to AZN stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 5.54%. On average, U.S. ETFs allocate 1.11% of AZN to their portfolios.

Additionally, AZN is a favorite stock for Active and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with AZN as a holding is the ProShares Ultra QQQ (QLD), with a return of 70.08%.